Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.
Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.
复制标题
DOI:
10.1016/j.ymthe.2021.09.012
复制
发表时间:
2022-02-02
期刊:
影响因子:
--
通讯作者:
Ling C
中科院分区:
文献类型:
--
作者:
Li M;Tang Y;Wang D;Zhai X;Shen H;Zhong C;Yao M;Jin A;Zhou Z;Zhou S;Fan J;Ling CQ;Ling C
Iron dyshomeostasis is associated with hepatocellular carcinoma (HCC) development. However, the role of iron in HCC metastasis is unknown. This study aimed to elucidate the underlying mechanisms of iron’s enhancement activity on HCC metastasis. In addition to the HCC cell lines and clinical samples in vitro, iron-deficient (ID) mouse models were generated using iron-free diet and transferrin receptor protein knockout, followed by administration of HCC tumors through either orthotopic or ectopic route. Clinical metastatic HCC samples showed significant ID status, accompanied by overexpression of sphingosine-1-phosphate transporter spinster homolog 2 (SPNS2). Mechanistically, ID increased SPNS2 expression, leading to HCC metastasis in both cell cultures and mouse models. ID not only altered the anti-tumor immunity, which was indicated by phenotypes of lymphatic subsets in the liver and lung of tumor-bearing mice, but also promoted HCC metastasis in a cancer cell autonomous manner through the SPNS2. Since germline knockout of globe SPNS2 showed significantly reduced HCC metastasis, we further developed hepatic-targeting recombinant adeno-associated virus vectors to knockdown SPNS2 expression and to inhibit iron-regulated HCC metastasis. Our observation indicates the role of iron in HCC pulmonary metastasis and suggests SPNS2 as a potential therapeutic target for the prevention of HCC pulmonary metastasis. Iron chelator was proposed in a clinical study of ten patients with advanced HCC. However, corresponding authors and colleagues observed that iron deficiency led to HCC pulmonary metastasis. Cancer cell SPNS2 is the underlying mechanism and a potential therapeutic target for the prevention of HCC pulmonary metastasis.
登录
查看更多内容
影响因子:
4.8
作者:
Ling, Chen;Wang, Yuan;Ling, Chang-Quan
通讯作者:
Ling, Chang-Quan
影响因子:
158.5
作者:
Llovet, Josep M.;Ricci, Sergio;Bruix, Jordi
通讯作者:
Bruix, Jordi
影响因子:
5.3
作者:
Cui, Juntao;Guo, Xinli;Xie, Junxia
通讯作者:
Xie, Junxia
影响因子:
3.7
作者:
Charlebois E;Pantopoulos K
通讯作者:
Pantopoulos K
DOI:
10.1073/pnas.1811717115
发表时间:
2018-10-23
影响因子:
11.1
作者:
Liang W;Li Q;Ferrara N
通讯作者:
Ferrara N